✨ Free AI Report
Saluda Medical: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Saluda Medical
Company Research

Saluda Medical: Business Overview, Financials & Competitive Analysis

Saluda Medical scores 7/10 on the AskCyborg Cyborg Score (Strong). Closed-loop spinal cord stimulation leader with clinical validation and institutional backing, transitioning from development to commercial scale in a large, underserved chronic pain market. Published clinical evidence in top-tier journals demonstrates superiority and long-term pain relief improvements, with $530M in funding from major investors like Boston Scientific. As of April.

What is Saluda Medical's industry? Saluda Medical (saludamedical.com) operates in Neurostimulation Devices. AskCyborg classifies Saluda Medical under Neurostimulation Devices in its company registry.

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders...

7/ 10Strong

Cyborg Score thesis

Closed-loop spinal cord stimulation leader with clinical validation and institutional backing, transitioning from development to...

Read the full analyst-debate transcript →
Industry Neurostimulation Devices
5 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 9, 2026
AI-Generated Research
30+ Page Report

Get the Latest Saluda Medical Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Saluda Medical

AskCyborg analysts argue the bull and bear cases for Saluda Medical across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Saluda Medical OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Saluda Medical Overview

Pro stress-test →

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company's first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain.

Strategic Profile

Pro stress-test →

The Evoke System instantaneously reads, records, and responds to the nerves' response to stimulation to provide continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. 12-month results from the EVOKE Study, the first double-blind randomized controlled trial (RCT) used in support of Premarket Approval (PMA) in spinal cord stimulation history, were published in The Lancet Neurology and 24-month results have since been published JAMA Neurology. Saluda Medical's latest funding was a Series F round on October 30, 2025, positioning the company for expanded commercialization.

Competitive Landscape

Pro stress-test →

Saluda Medical competes with companies including Nalu Medical, Nuvectra and Clearing in the neuromodulation space. As the only ECAP-controlled closed-loop SCS player with published clinical superiority data, Saluda holds differentiation versus traditional open-loop competitors. The market is dominated by established players offering open-loop systems, creating opportunity for closed-loop innovation.

Industry Context

Saluda Medical operates in Neurostimulation Devices.

Key facts

Founded: 2010 · Headquarters: Bloomington, Minnesota, US · Employees: 483 · Revenue: $20.2M (2026)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Saluda Medical.

  • First RCT-based PMA approval in spinal cord stimulation history, with results published in leading neurology journals
  • Evoke System automatically adjusts stimulation over 4 million times per day based on real-time neural signals, delivering personalized therapy
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2025Series F funding round completed, supporting commercial expansion
  • April 2026Employee count reached 483, indicating scaling of sales and operations
  • +1 moreTrack every material event for Saluda Medical as it happens. Explore monitoring →
Get alerted when Saluda Medical has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Nalu MedicalNeuromodulation and pain management→Abbott Pain ManagementOpen-loop spinal cord stimulation systems→Boston Scientific Pain ManagementSpinal cord stimulation and neuromodulation→NevroHigh-frequency spinal cord stimulation systems→MedtronicSpinal cord stimulation and neuromodulation devices→

Compare Saluda Medical with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Saluda Medical operates in Neurostimulation Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Neurostimulation Devices research →
NEW · MCP server

Ask your AI assistant about Saluda Medical

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Saluda Medical and its top competitor on Cyborg Score”
“What did Saluda Medical do this quarter?”
“Is Saluda Medical a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Saluda Medical do?+
Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders...
What is Saluda Medical's Cyborg Score?+
Saluda Medical has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Saluda Medical's main competitors?+
Named competitors include Nalu Medical, Abbott Pain Management, Boston Scientific Pain Management, Nevro. The full competitive landscape is in the AskCyborg report.
How can I get the full Saluda Medical research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Saluda Medical research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Saluda Medical over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Neurostimulation Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Medtronic plc